US 10314908
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted A61KA61K2039/55561A61K31/00
Quick answer
US patent 10314908 (Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation) held by The United States of America as represented by the Secretary of the Department of expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Department of
- Grant date
- Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/55561, A61K31/00, A61K31/365, A61K31/519